Stay updated with breaking news from Mark Litton. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Athira Pharma Reports Full Year 2021 Financial Results and Provides Clinical Update On track to report topline data from ACT-AD Phase 2 Alzheimer's disease study in 2Q22 ... | March 24, 2022
The chief executive Athira Pharma left the company after papers she published as a student were found to contain altered research.
Leen Kawas has formally resigned as CEO and president of Athira Pharma and is stepping off the board after an investigation found the biotech executive altered…
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Athira Pharma climbs on Alzheimer study news, while the CEO steps down over altered images in her research papers and dissertation.